Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY

DOI: https://doi.org/10.29296/25879979-2019-07-09
Download full text PDF
Issue: 
7
Year: 
2019

O.B. Poselyugina, MD; L.N. Korichkina, MD; V.N. Borodina, L.N. Al-Galban Tver State Medical University 4, Sovetskaya St., Tver 170100, Russian Federation

The paper considers modern ideas about human immunodeficiency virus-associated nephropathy. It discloses the features of pathogenesis and clinical manifestations and the subtleties of diagnosis and treatment of this pathology.
Keywords: 
human immunodeficiency virus
AIDS
nephropathy
kidney biopsy
renal failure

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Dannye Rosstata po zabolevaemosti VICh. https: http://www.gks.ru/free_doc/doc_2018/social/osn-04-2018.pdf
  2. VICh-infektsija. Informatsionnyj bjulleten' Federal'nogo nauchno-metodicheskogo tsentra po profilaktike i bor'be so SPIDom Tsentral'nogo NII epidemiologii. Moskva.
  3. Volgina G.V., Gadzhikulieva M.M. Natsional'nye klinicheskie rekomendatsii. Hronicheskaja bolezn' pochek u VICh-infitsirovannyh patsientov. M., 2015; 34.
  4. Natsional'nye klinicheskie rekomendatsii po dispansernomu nabljudeniju i lecheniju bol'nyh VICh-infektsiej. Klinicheskij protokol. 2016; 72.
  5. Rekomendatsii Evropejskogo klinicheskogo obschestva SPIDa, versija 9,0. 2017; 104.
  6. VICh-infektsija i SPID: klinicheskie rekomendatsii. Pod red. V.V. Pokrovskogo. 3-e izd., pererab. i dop. M.: GOETAR-Media, 2016; 112.
  7. Juschuk N., Gadzhikulieva M., Volgina G., Tomilina N. Glomeruljarnye zabolevanija u VICh-infitsirovannyh patsientov: klinicheskaja i morfologicheskaja otsenka. Terapevt arhiv. 2012; 11: 30–3.
  8. Libman G., Makadon H. Dzh. VICh-infektsii. Per. s angl.; pod red. A.I. Mazusa, T.P. Bessaraba. M.: GEOTAR-Media, 2012; 560.
  9. Zhuravleva M.S., Skvortsov V.V. Printsipy diagnostiki i lechenija VICh-infektsii. Meditsinskaja sestra. 2016; 7: 14–21.
  10. Burns G., Paul S., Toth I. et al. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J. Am. Soc. Nephrol. 1997; 8: 1140–6.
  11. Cosgrove C., Abu–Alfa A., Perazella M. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am. J. Med. Sci. 2002; 323 (2): 102–6.
  12. Ting–chi L., Ross M. HIV-associated nephropathy: a brief review. Mount Sinai J. Med. 2005; 75 (3): 193–9.
  13. United States Renal Data System 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2003.
  14. Wei A., Burns G., Williams B. et al. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int. 2003; 64 (4): 1462–71.
  15. Winston J., Bruggeman L., Ross M. et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 2001; 344 (26): 1979–84.
  16. Woolley I., Kalayjian R., Valdez H. et al. HIV nephropathy and the Duffy antigen. Receptor for Chemokines in African Americans. J. Nephrol. 2001; 14: 384–7.
  17. Transplantatsija pochki. Natsional'nye klinicheskie rekomendatsii. 2013; 50